Content about New Drugs & OTCs

March 29, 2013

Vitamin Squeeze announced the release of a full line of powdered water enhancers available in supermarkets nationwide.

March 28, 2013

Hamacher Resource Group has been invited to present a continuing education session, “Bottom Line Performance: Opportunities and Actions,” at the Mutual Drug Spring CE Forum on April 7 in Raleigh, N. C., the company announced.

March 28, 2013

Itonis Pharmaceuticals unveiled the company's initial marketing plans for an over-the-counter homeopathic product that helps relieve nausea.

March 27, 2013

The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

March 27, 2013

The Food and Drug Administration has approved a new treatment for multiple sclerosis made by Biogen Idec, the agency said.

March 27, 2013

Pharmacies using McKesson EnterpriseRx pharmacy-management system can send patients information about health clinics, drug recalls, coupons and real-time surveys through their mobile phones using an integrated mobile communication system.

March 26, 2013

The Food and Drug Administration has approved a drug for opioid dependence made by Actavis, the company said.

March 26, 2013

GNC extended its Preventive Nutrition brand to help supplement a number of conditions, including eye health, liver health and digestive health.

March 25, 2013

Generic drug maker Actavis has reached a deal with AstraZeneca that will allow it to launch a version of a drug used to treat cholesterol in three years, Actavis said Monday.

March 25, 2013

More than 400 drugs are under development for the 10 most common chronic health conditions affecting elderly people, according to a new report by a drug industry trade group.

March 25, 2013

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

March 25, 2013

Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said.

March 25, 2013

SanMedica International introduced its SeroVital-HGH, a new oral human-growth hormone booster formulated with women in mind, at the Academy of Women's Health's Annual Congress.

March 21, 2013

Alcon has launched a mobile website designed to facilitate dialogue between patients and pharmacists about eye and ear treatments, the company said.

March 21, 2013

New Chapter voluntarily recalled a limited number of packages of its 90-count Probiotic Elderberry dietary supplement because it may contain an undeclared allergen - soy.

March 20, 2013

Hamacher Resource Group is offering pharmacists a new service that it said would allow them to get the top prescriptions dispensed in their two-digit ZIP code to ensure they are accurately and competitively pricing drugs.

March 20, 2013

The Food and Drug Administration has approved and launched two generic contraceptives made by Sandoz, the drug maker said.

March 18, 2013

Galena Biopharma has purchased rights to a treatment for breakthrough cancer pain from a Swedish drug maker, Galena said Monday.

March 18, 2013

Perrigo announced that it has begun shipments of guaifenesin 600-mg extended-release tablets. It's the first product that is generically equivalent to Reckitt Benckiser's Mucinex 600-mg extended-release tablets.

March 18, 2013

Robinson Pharma introduced its Unique IS-2 Probiotic Softgel in collaboration with B&D Nutritional Ingredients and Unique Biotech USA.

March 15, 2013

Cardium Therapeutics announced its To Go Brands operating unit has expanded its VitaRocks kids' vitamins product line and that retail distribution has been expanded into select Target stores.

March 14, 2013

Mylan has settled a patent-infringement lawsuit filed by Shionogi over its generic version of a drug for diabetes, Mylan said.

March 14, 2013

Wegmans will be offering the popular cholesterol-lowering drug atorvastatin free of charge through the end of the year, according to a report published by the Philadelphia Inquirer.

March 12, 2013

Actavis is challenging Novartis' patent on a patch used to treat Alzheimer's disease, Actavis said.

© 2013 Drug Store News. All Rights Reserved.